Contrasting Halberd (HALB) and Its Peers
Halberd (OTCMKTS:HALB – Free Report) is one of 361 publicly-traded companies in the “Biotechnology” industry, but how does it contrast to its competitors? We will compare Halberd to related companies based on the strength of its analyst recommendations, valuation, risk, profitability, dividends, institutional ownership and earnings. Insider & Institutional Ownership 22.1% of shares of all […]